Ophthotech Corp (OPHT), Novartis Enter ex-US Licensing Agreement for Wet … – StreetInsider.com (subscription)

Ophthotech Corp (OPHT), Novartis Enter ex-US Licensing Agreement for Wet
StreetInsider.com (subscription)
Ophthotech Corporation (Nasdaq: OPHT) announced that the Company has entered into an ex-US licensing and commercialization agreement with Novartis Pharmaceuticals (NYSE: NVS) focused on the treatment of wet age-related macular degeneration
Novartis announces exclusive agreement to extend leadership in ophthalmology MarketWatch
Ophthotech licenses experimental eye drug to NovartisWTAQ
Ophthotech Corp. (OPHT) Is Up Sharply After Novartis AgreementRTT News

all 6 news articles

…read more

Source: Wet Macular Degeneration News From Google News

Leave a Comment